Varamir
Desk
News
Calendar
Pricing
Saved
Search
tickers or companies
⌘K
Start free
· no card
Sign in
LBRX compared with IPSC: revenue, margins and what each company keeps, and the suppliers and customers both name
LBRX
LB Pharmaceuticals Inc
Change
Mkt cap
Revenue
Revenue
IPSC
Century Therapeutics, Inc.
Change
Mkt cap
Revenue
Revenue
vs
Compare
LBRX
LB Pharmaceuticals Inc
vs
IPSC
Century Therapeutics, Inc.
Price
Mkt cap
Revenue
Revenue
Change
Change
Revenue flow
Supply chain
Price
Co-movers
Event sensitivity
Earnings history
Save comparison
Copy link
Price
Desk
News
Calendar
Saved
Search
LBRX
LB Pharmaceuticals Inc
Change
39.10
▼
−1.50%
· post 39.09
Mkt cap
$1.2B
Revenue
—
Revenue
—
IPSC
Century Therapeutics, Inc.
Change
1.47
0.00%
Closed
Nov 2 '26
Mkt cap
$266.2M
Revenue
$109M
Q1 FY25
Revenue
$7M
FY24
vs
Compare
Closed
Nov 2 '26
LBRX
LB Pharmaceuticals Inc
vs
IPSC
Century Therapeutics, Inc.
39.10
▼
−1.50%
post 39.09
Price
1.47
0.00%
$1.2B
Mkt cap
$266.2M
—
Revenue
$109M
Q1 FY25
—
Revenue
$7M
FY24
Change
Change
LBRX
39.10
▼
−1.50%
vs
IPSC
1.47
0.00%
Closed
Nov 2 '26
Price
rebased to 0%
1D
1W
1M
3M
YTD
1Y
5Y
1D
1W
1M
3M
YTD
1Y
5Y
LBRX, solid
IPSC, dashed